Human papilloma virus and cervical preinvasive disease
2009

Human Papillomavirus and Cervical Preinvasive Disease

publication Evidence: moderate

Author Information

Author(s): Gheorghe Peltecu, Bari M, Iancu G, Popa F

Primary Institution: Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

Hypothesis

The study investigates the role of HPV in cervical preinvasive disease and the effectiveness of vaccination.

Conclusion

Vaccination against HPV can significantly prevent cervical cancer by protecting against the most aggressive HPV types.

Supporting Evidence

  • HPV is responsible for 99.7% of cervical cancer cases.
  • The vaccination is recommended for girls aged 11-12.
  • Screening has dramatically reduced the incidence of cervical cancer.
  • Most HPV infections regress spontaneously, especially in young women.

Takeaway

HPV is a virus that can cause cervical cancer, but we can prevent it with a vaccine, especially for young girls.

Methodology

The study reviews clinical and molecular studies on HPV and cervical cancer, discussing prevention and treatment strategies.

Limitations

The study does not provide specific data on the effectiveness of vaccination in women aged 19 to 26.

Participant Demographics

The study focuses on women, particularly young girls aged 11-12 for vaccination.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication